TruCheck™ - Early Cancer Screening Blood Test

TruCheck™ - Early Cancer Screening Blood Test. What is TruCheck™? TruCheck™ is an advanced blood test specifically designed for early cancer screening. This innovative test uses cutting-edge technology to detect cancer markers in the bloodstream, allowing... Read more

TruCheck™ - Early Cancer Screening Blood Test.

What is TruCheck™?

TruCheck™ is an advanced blood test specifically designed for early cancer screening. This innovative test uses cutting-edge technology to detect cancer markers in the bloodstream, allowing for timely diagnosis and treatment. Because early detection is crucial for successful cancer treatment, TruCheck™ aims to provide individuals and healthcare providers with a reliable tool for monitoring health. The test can be performed easily in a clinical setting, making it accessible for everyone.

How TruCheck™ Works

The process behind TruCheck™ involves analysing a small sample of blood for specific biomarkers associated with various types of cancer. These biomarkers indicate potential abnormalities in the body, signaling the presence of cancer at an early stage. The test results are quick and efficient, which means patients can receive crucial information about their health without unnecessary delays. So, by using TruCheck™, individuals can take significant steps towards proactive health management.

Benefits of Early Cancer Detection

Early cancer detection significantly increases the chances of successful treatment and recovery. With TruCheck™, the earlier cancer is identified, the more options there are for treatment, which can lead to better health outcomes. Additionally, this blood test provides peace of mind, empowering individuals to take control of their health. It is important to remember that while TruCheck™ is a powerful tool, regular check-ups and conversations with healthcare providers are also essential for maintaining overall health and well-being.

Read less
  • Venous Sample
  • 70 Solid Organ Cancers Distinguished
  • Early Cancer Screening
  • 200+ Clinic Locations
  • Free Telephone Doctor Consultation
Up to 70 types of solid cancer tumours detected
Check Availability (Based on location)
  • Clearpay
  • Splitit
  • Visa
  • Mastercard
  • Apple Pay
  • Shop Pay
  • Google Pay

What does the
TruCheck test offer?

Our TruCheck Intelli Early Multi-Cancer Screening blood test checks your blood sample for Circulating Tumour Cells (CTCs), and clusters of the cells.

Experts you can trust

Not sure if this test
is right for you?

Enquire via the form and a member of our team will get back to you, they are more than happy to help answer your questions and talk through the best option for you.

Contact us if you aren’t sure, we’d be happy to help!

You can call us today on 01225 444 144

Register Your Interest

As featured in

Delivering affordable testing to everybody.

Highly Recommended

“I was recommended TruCheck by a friend of mine and at the age of 64, cancer has always been on mind”

“Through the consultation with the lovely Goodbody doctor she informed me of the science and how it looks for small cells of cancer in my blood and if found I could act early on it.”

“Luckily my test was negative and it has given me a lot of reassurance.”

“I would highly recommend taking this test with Goodbody Clinic, and will definitely be booking another for next year to keep track of my health.”

Ronny H., from Somerset.

How does the TruCheck test process work??

UK based Doctor Consultation.

Kit delivered to take to your appointment.

Laboratory analysis and results in 2-3 weeks.

Why is this test so revolutionary?

Launched in the UK in late 2022 after rigorous clinical trials, this test is brand new to the screening industry. It is the only test available publicly to check for Circulating Tumour Cells (CTCs), detecting even the tiniest existence of cancer from a small blood sample.

Adenocarcinoma

Squamous Cell Carcinoma

Adenosquamous Carcinoma

Neuroendocrine

Renal Cell Carcinoma

Transitional Cell Carcinoma

Gastrointestinal Stromal tumors

Melanomas

Mesothelioma

Sarcomas

Sarcomas

Glioma

Some key
considerations.

What if my results come back as ‘positive’?

Launched in the UK in late 2022 after rigorous clinical trials, this test is brand new to the screening industry. It is the only test available publicly to check for Circulating Tumour Cells (CTCs), detecting even the tiniest existence of cancer from a small blood sample.

Does a ‘negative’ result mean that I am ‘totally’ cancer free?

A negative result means that at the time of the test there were no detectable cancer cells for the cancers included within the test, circulating in your blood. It does not mean that you will never develop cancer. For any cancers not covered by the test, no inference should be drawn from a negative result.

Are there any restrictions on who can take this test?

We have certain clinical requirements that you must fulfil in order to be eligible to take this test. You will need to complete an online form when you checkout to confirm these and they will be checked during a pre-consultation call with our Doctor.

Be 40 years of age or older. (35 – 40 year olds accepted subject to being deemed high risk, please enquire)

Not have any symptoms of cancer currently. If you have suspected symptoms, you should visit your GP urgently.

Not have any clinical or radiological suspicion of cancer currently.

Have not ever been diagnosed with any type of cancer.

Have not previously had any treatment for any type of cancer.

Not have a blood transfusion within 72 hours of your blood draw appointment.


Please ensure you carefully review the eligibility criteria mentioned above before booking the test, as failure to meet the criteria or any subsequent changes may result in the test being declined during the pre-consultation, and a refund will be issued minus the cost of the GP’s pre-consultation.

How frequently should I take this test?

As this early cancer screening test is non-invasive, there is no disadvantage to frequent testing. However, we advise that this test should be performed every 12 months in the case of each negative result, perhaps as part of an annual complete health check process.

What’s the difference between the TruCheck and Galleri Grail test?

As this early cancer screening test is non-invasive, there is no disadvantage to frequent testing. However, we advise that this test should be performed every 12 months in the case of each negative result, perhaps as part of an annual complete health check process.

FAQs

PLACING AN ORDER

Which test should I choose?

How does the service work?

When will my order arrive?

How accurate are your tests?

I've just paid, can I change my order?

Can I order a test for someone else?

Why do I need a kit for my appointment?

How often should I take my test?

ARRANGING AN APPOINTMENT

How do I book an appointment?

How is the test carried out?

Do I need to fast before my test?

I am nervous about my blood test appointment.

Do I need to take my kit to my appointment?

AFTER YOUR TEST

My blood was haemolysed - what does that mean?

Do you provide results 7 days a week?

How do I book a follow up GP consultation?

We promise to deliver affordable testing to everybody.

When you’re worried about your health, life can feel very stressful, especially if you don’t have the answers you need. We believe that health testing should be available to all, giving you answers when and where you need them.

That’s why we’ve partnered with Splitit, Dopple and Clearpay so you can pay for your tests in interest-free instalments, if you prefer.

Experts you can trust

The numbers speak for themselves.

250,000+

Tests completed

200+

Clinics

Years

Industry Experience